It is possible that patients like the one reported here, with a truncated protein encoded by one allele and a misfolded protein encoded by the other, may require a different promoter and multiplicity of infection than a different patient who harbors two stop mutations in USH2A. Patient-specific iPSC-derived retinal cells may be useful in choosing the optimal gene therapy strategy for each individual. Here, USH2A is linked to infection.